{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T11:26:29Z","timestamp":1773746789150,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2017,9,27]],"date-time":"2017-09-27T00:00:00Z","timestamp":1506470400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"\u201cTwelve Five\u201d National Key Technology R & D Program of China","award":["No. 2011BAI11B05"],"award-info":[{"award-number":["No. 2011BAI11B05"]}]},{"name":"Beijing Natural Science Foundation of China","award":["No. 7132078"],"award-info":[{"award-number":["No. 7132078"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 81370437"],"award-info":[{"award-number":["No. 81370437"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Herz"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s00059-017-4620-z","type":"journal-article","created":{"date-parts":[[2017,9,27]],"date-time":"2017-09-27T03:53:10Z","timestamp":1506484390000},"page":"733-740","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Effect of pioglitazone on inflammation and calcification in atherosclerotic rabbits","Wirkung von Pioglitazon auf Entz\u00fcndung und Verkalkung bei Kaninchen mit Arteriosklerose"],"prefix":"10.1007","volume":"43","author":[{"given":"J.","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Nie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3457-4953","authenticated-orcid":false,"given":"Q.","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,9,27]]},"reference":[{"issue":"5","key":"4620_CR1","doi-asserted-by":"crossref","first-page":"351","DOI":"10.5551\/jat.7591","volume":"18","author":"Y Mizuno","year":"2011","unstructured":"Mizuno Y, Jacob RF, Mason RP (2011) Inflammation and the development of atherosclerosis [J]. J\u00a0Atheroscler Thromb 18(5):351\u2013358","journal-title":"J Atheroscler Thromb"},{"key":"4620_CR2","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1161\/CIRCRESAHA.110.234419","volume":"108","author":"DA Towler","year":"2011","unstructured":"Towler DA, Demer LL (2011) Thematic series on the pathobiology of vascular calcification: an introduction. Circ Res 108:1378\u20131380","journal-title":"Circ. Res."},{"key":"4620_CR3","doi-asserted-by":"crossref","first-page":"14678","DOI":"10.1073\/pnas.0606310103","volume":"103","author":"Y Vengrenyuk","year":"2006","unstructured":"Vengrenyuk Y, Carlier S, Xanthos S et\u00a0al (2006) A hypothesis for vulnerable plaque rupture due to stressinduced debonding around cellular microcalcifications in thin fibrous caps. Proc Natl Acad Sci Usa 103:14678\u201314683","journal-title":"Proc Natl Acad Sci Usa"},{"issue":"1","key":"4620_CR4","doi-asserted-by":"crossref","first-page":"61","DOI":"10.7326\/0003-4819-134-1-200101020-00014","volume":"134","author":"AA Parulkar","year":"2001","unstructured":"Parulkar AA, Pendergrass ML, Granda-Ayala R et al (2001) Nonhypoglycemic effects of thiazolidinediones [J]. Ann Intern Med 134(1):61\u201371","journal-title":"Ann. Intern. Med."},{"issue":"6","key":"4620_CR5","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.tips.2004.03.012","volume":"25","author":"SM Rangwala","year":"2004","unstructured":"Rangwala SM, Lazar MA (2004) Peroxisome proliferator-activated receptor gamma in diabetes and metabolism [J]. Trends Pharmacol Sci 25(6):331\u2013336","journal-title":"Trends Pharmacol Sci"},{"issue":"5","key":"4620_CR6","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.tem.2012.03.001","volume":"23","author":"B Cariou","year":"2012","unstructured":"Cariou B, Charbonnel B, Staels B (2012) Thiazolidinediones and PPARgamma agonists: Time for a\u00a0reassessment [J]. Trends Endocrinol Metab 23(5):205\u2013215","journal-title":"Trends Endocrinol Metab"},{"key":"4620_CR7","doi-asserted-by":"publisher","DOI":"10.1007\/s00059-017-4620-z","author":"MA Deeg","year":"2008","unstructured":"Deeg MA, Tan MH (2008) Pioglitazone versus Rosiglitazone: Effects on lipids, lipoproteins, and apolipoproteins in head-to-head randomized clinical studies [J]. PPAR Res:520465. \n                        https:\/\/doi.org\/10.1007\/s00059-017-4620-z","journal-title":"PPAR Res"},{"issue":"3","key":"4620_CR8","doi-asserted-by":"crossref","first-page":"64","DOI":"10.7812\/TPP\/09-052","volume":"14","author":"A Krishnaswami","year":"2010","unstructured":"Krishnaswami A, Ravi-Kumar S, Lewis JM (2010) Thiazolidinediones: a\u00a02010 perspective [J]. Perm\u00a0J 14(3):64\u201372","journal-title":"Perm J"},{"key":"4620_CR9","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1001\/jama.298.10.1180","volume":"298","author":"AM Lincoff","year":"2007","unstructured":"Lincoff AM, Wolski K, Nicholls SJ et al (2007) Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: A\u00a0meta-analysis of randomized trials. JAMA 298:1180\u20131188","journal-title":"JAMA"},{"issue":"5","key":"4620_CR10","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/MOL.0000000000000105","volume":"25","author":"JD Hutcheson","year":"2014","unstructured":"Hutcheson JD, Maldonado N, Aikawa E (2014) Small entities with large impact: microcalcifications and atherosclerotic plaque vulnerability. Curr Opin Lipidol 25(5):327\u2013332","journal-title":"Curr Opin Lipidol"},{"key":"4620_CR11","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/j.amjcard.2004.08.013","volume":"94","author":"ER Mohler 3rd","year":"2004","unstructured":"Mohler ER 3rd (2004) Mechanisms of aortic valve calcification. Am J Cardiol 94:1396\u20131402","journal-title":"Am J Cardiol"},{"issue":"5","key":"4620_CR12","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/ncpcardio0827","volume":"4","author":"NM Rajamannan","year":"2007","unstructured":"Rajamannan NM, Bonow RO, Rahimtoola SH (2007) Calcific aortic stenosis: an update. Nat Clin Pract Cardiovasc Med 4(5):254\u2013262","journal-title":"Nat Clin Pract Cardiovasc Med"},{"issue":"13","key":"4620_CR13","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMe0807001","volume":"359","author":"CM Otto","year":"2008","unstructured":"Otto CM (2008) Calcific aortic stenosis\u2014time to look more closely at the valve. N Engl J Med 359(13):1395\u20131398","journal-title":"N. Engl. J. Med."},{"key":"4620_CR14","first-page":"114","volume":"14","author":"M Beheshti","year":"2011","unstructured":"Beheshti M, Saboury B, Mehta NN et al (2011) Detection and global quantification of cardiovascular molecular calcification by fluoro18-fluoride positron emission tomography\/computed tomography\u2014a\u00a0novel concept. Hell J Nucl Med 14:114\u2013120","journal-title":"Hell J Nucl Med"},{"key":"4620_CR15","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.jacc.2011.03.044","volume":"58","author":"EJ Folco","year":"2011","unstructured":"Folco EJ, Sheikine Y, Rocha VZ et al (2011) Hypoxia but not inflammation augments glucose uptake in human macrophages: Implications for imaging atherosclerosis with 18fluorine-labeled 2\u2011deoxy-dglucose positron emission tomography. J\u00a0Am Coll Cardiol 58:603\u2013614","journal-title":"J Am Coll Cardiol"},{"key":"4620_CR16","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.amjcard.2011.11.060","volume":"109","author":"F Hyafil","year":"2012","unstructured":"Hyafil F, Messika-Zeitoun D, Burg S et al (2012) Detection of 18fluoride sodium accumulation by positron emission tomography in calcified stenotic aortic valves. Am J Cardiol 109:1194\u20131196","journal-title":"Am. J. Cardiol."},{"key":"4620_CR17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1161\/CIRCULATIONAHA.111.073452","volume":"125","author":"E Aikawa","year":"2012","unstructured":"Aikawa E, Otto CM (2012) Look more closely at the valve: imaging calcific aortic valve disease. Circulation 125:9\u201311","journal-title":"Circulation"},{"issue":"2","key":"4620_CR18","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1161\/CIRCIMAGING.113.001508","volume":"7","author":"MR Dweck","year":"2014","unstructured":"Dweck MR, Jenkins WS, Vesey AT et\u00a0al (2014) 18F-sodium fluoride uptake is a\u00a0marker of active calcification and disease progression in patients with aortic stenosis. Circ Cardiovasc Imaging 7(2):371\u2013378","journal-title":"Circ Cardiovasc Imaging"},{"key":"4620_CR19","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1161\/CIRCULATIONAHA.111.051052","volume":"125","author":"MR Dweck","year":"2012","unstructured":"Dweck MR, Jones C, Joshi NV et\u00a0al (2012) Assessment of valvular calcification and inflammation by positron emission tomography in patients with aortic stenosis. Circulation 125:76\u201386","journal-title":"Circulation"},{"issue":"6","key":"4620_CR20","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0002-9149(01)01821-5","volume":"88","author":"WS Aronow","year":"2001","unstructured":"Aronow WS, Ahn C, Kronzon I, Goldman ME (2001) Association of coronary risk factors and use of statins with progression of mild valvular aortic stenosis in older persons. Am J Cardiol 88(6):693\u2013695","journal-title":"Am. J. Cardiol."},{"issue":"10","key":"4620_CR21","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/S0735-1097(02)02496-8","volume":"40","author":"MF Bellamy","year":"2002","unstructured":"Bellamy MF, Pellikka PA, Klarich KW et\u00a0al (2002) Association of cholesterol levels, hydroxymethylglutaryl coenzyme\u2014a reductase inhibitor treatment, and progression of aortic stenosis in the community. J\u00a0Am Coll Cardiol 40(10):1723\u20131730","journal-title":"J. Am. Coll. Cardiol."},{"key":"4620_CR22","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1161\/hc4301.098249","volume":"104","author":"GM Novaro","year":"2001","unstructured":"Novaro GM, Tiong IY, Pearce GL et\u00a0al (2001) Effect of hydroxymethylglutaryl coenzyme a\u00a0reductase inhibitors on the progression of calcific aortic stenosis. Circulation 104:2205\u20132209","journal-title":"Circulation"},{"key":"4620_CR23","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1056\/NEJMoa043876","volume":"352","author":"SJ Cowell","year":"2005","unstructured":"Cowell SJ, Newby DE, Prescott RJ et al (2005) A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N\u00a0Engl J Med 352:2389\u20132397","journal-title":"N Engl J Med"},{"key":"4620_CR24","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJMoa0804602","volume":"359","author":"AB Rossebo","year":"2008","unstructured":"Rossebo AB, Pedersen TR, Boman K et\u00a0al (2008) Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N\u00a0Engl J Med 359:1343\u20131356","journal-title":"N Engl J Med"},{"key":"4620_CR25","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/34178","volume":"391","author":"M Ricote","year":"1998","unstructured":"Ricote M, Li AC, Willson TM et al (1998) The peroxisome proliferator-activated receptor-gamma is a\u00a0negative regulator of macrophage activation. Nature 391:79\u201382","journal-title":"Nature"},{"key":"4620_CR26","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.pharmthera.2005.08.007","volume":"110","author":"LA Moraes","year":"2006","unstructured":"Moraes LA, Piqueras L, Bishop-Bailey D (2006) Peroxisome proliferator-activated receptors and inflammation. Pharmacol Ther 110:371\u2013385","journal-title":"Pharmacol Ther"},{"key":"4620_CR27","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1056\/NEJMoa072761","volume":"356","author":"SE Nissen","year":"2007","unstructured":"Nissen SE, Wolski K (2007) Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N\u00a0Engl J Med 356:2457\u20132471","journal-title":"N Engl J Med"},{"issue":"4","key":"4620_CR28","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1001\/jama.2010.920","volume":"304","author":"DJ Graham","year":"2010","unstructured":"Graham DJ, Ouellet-Hellstrom R, Macurdy TE et al (2010) Risk of acute myocardial infarction, stroke, heart failure, and death in elderly Medicare patients treated with rosiglitazone or pioglitazone[J. JAMA 304(4):411\u2013418","journal-title":"JAMA"},{"issue":"3","key":"4620_CR29","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1253\/circj.CJ-11-0060","volume":"75","author":"N Wang","year":"2011","unstructured":"Wang N, Yin R, Liu Y et al (2011) Role of peroxisome proliferator-activated receptor-gamma in atherosclerosis: an update. Circ\u00a0J 75(3):528\u2013535","journal-title":"Circ J"},{"issue":"10","key":"4620_CR30","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.jcmg.2011.04.020","volume":"4","author":"E Vucic","year":"2011","unstructured":"Vucic E, Dickson SD, Calcagno C et al (2011) Pioglitazone modulates vascular inflammation in atherosclerotic rabbits noninvasive assessment with FDG-PET-CT and dynamic contrast-enhanced MR imaging. JACC Cardiovasc Imaging 4(10):1100\u20131109","journal-title":"JACC Cardiovasc Imaging"},{"key":"4620_CR31","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0735-1097(96)00563-3","volume":"29","author":"BF Stewart","year":"1997","unstructured":"Stewart BF, Siscovick D, Lind BK et\u00a0al (1997) Clinical factors associated with calcific aortic valve disease.Cardiovascular Health Study. J\u00a0Am Coll Cardiol 29:630\u2013634","journal-title":"J Am Coll Cardiol"}],"container-title":["Herz"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00059-017-4620-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-017-4620-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-017-4620-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,12,3]],"date-time":"2018-12-03T08:23:46Z","timestamp":1543825426000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00059-017-4620-z"}},"subtitle":["An 18F-FDG-PET\/CT in vivo imaging study","Eine 18F-FDG-PET-CT-in-vivo-Bildgebungsstudie"],"short-title":[],"issued":{"date-parts":[[2017,9,27]]},"references-count":31,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["4620"],"URL":"https:\/\/doi.org\/10.1007\/s00059-017-4620-z","relation":{},"ISSN":["0340-9937","1615-6692"],"issn-type":[{"value":"0340-9937","type":"print"},{"value":"1615-6692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,27]]}}}